ACBM (Acro Biomedical Co) Moat Score: 2/10 (As of Jun. 30, 2026)


What is Acro Biomedical Co Moat Score?

Acro Biomedical Co ACBM Moat Score is 2 as of Jun. 30, 2026. The stock has 2 warning signs investors should review. Among 594 Diversified Financial Services companies, Acro Biomedical Co ranks better than 96.46% on this metric.

Acro Biomedical Co has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Acro Biomedical Co has No Moat: Acro Biomedical operates in a highly competitive biotech sector with no significant market share or intellectual property that provides a competitive edge. The company lacks brand strength, customer loyalty, and durable cost advantages, resulting in a very weak moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Acro Biomedical Co might have No Moat - Very weak/transient advantages.

Acro Biomedical Co  (OTCPK:ACBM) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Acro Biomedical Co Moat Score Related Terms

ACBM vs RNGC, EEGI, GMZP: Moat Score Comparison

For the Shell Companies subindustry, Acro Biomedical Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acro Biomedical Co Moat Score vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Acro Biomedical Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Acro Biomedical Co (ACBM) has a Moat Score of 2 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Acro Biomedical Co ranks #21 out of 594 companies in the Diversified Financial Services industry, placing it in the top 3.5%.
Is Acro Biomedical Co's Moat Score too high?
Acro Biomedical Co's current Moat Score is 2. Based on the distribution chart, Acro Biomedical Co ranks #21 out of 594 companies in the Diversified Financial Services industry, which is in the top quartile — a strong position relative to peers.
How does Acro Biomedical Co's Moat Score compare to RNGC and EEGI?
According to the Diversified Financial Services industry distribution chart, Acro Biomedical Co ranks #21 out of 594 companies for Moat Score. This places Acro Biomedical Co in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Diversified Financial Services company?
A good Moat Score depends on the Diversified Financial Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Acro Biomedical Co's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acro Biomedical Co stock overvalued right now?
Acro Biomedical Co (ACBM) has a current Moat Score of 2. The current Moat Score is 2. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Acro Biomedical Co (ACBM), the current Moat Score is 2 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acro Biomedical Co Business Description

Address 12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd is a shell company.